Nutriment preparation

• US 5,492,713 A
• Filed: 08/05/1994
• Issued: 02/20/1996
• Est. Priority Date: 05/16/1991
• Status: Expired due to Fees

• Current Assignee: Klaus Sommermeyer
• Original Assignee: Klaus Sommermeyer
• Inventors: Sommermeyer, Klaus
• Primary Examiner(s): PADEN, CAROLYN A
• Application Number:
  US08/150,039
• Time in Patent Office: 564 Days
• Field of Search: 426/601, 426/606
• US Class Current: 426/601
• CPC Class Codes: A23L 33/12 Fatty acids or derivatives thereof
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/00 Medicinal preparations containing organic active ingredients
• CPC Class Codes: A61K 31/22 of acyclic acids, e.g. pravastatin
• CPC Class Codes: A61K 31/23 of acids having a carboxyl group bound to a chain of seven or more carbon atoms
• CPC Class Codes: A61K 33/00 Medicinal preparations containing inorganic active ingredients
• CPC Class Codes: A61P 13/02 of urine or of the urinary tract, e.g. urine acidifiers
• CPC Class Codes: A61P 15/00 Drugs for genital or sexual disorders for disorders of sex hormones A61P5/24; Contraceptives
• CPC Class Codes: A61P 3/00 Drugs for disorders of the metabolism of the blood or the extracellular fluid A61P7/00
• CPC Class Codes: A61P 3/02 Nutrients, e.g. vitamins, minerals
• CPC Class Codes: A61P 3/06 Antihyperlipidemics
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: C07C 69/30 esterified with trihydroxylic compounds fats, oils C11B, C11C

Abstract

The present invention concerns nutriment preparations for humans and animals which are suited in particular for ureamic patients and for clinical nutrition and which contain as an energy substrate at least one glycerid hard to dissolve resp. insoluble in water with at least one branched-chain fatty acid derived from the residue of the general Formula II ##STR1## wherein R designates a methyl residue or an ethyl residue, m designates 0 or 1, preferably 1, and n designates 0 or an even number between 2 and 18, preferably 0 or an even number between 2 and 6 and in particular 0, 2 or 4. The preparations according to the invention are suited for the treatment of severe trauma and sepsis and, in particular, for the treatment of ureamic patients, e.g. during chronic kidney insufficiency, of urea synthesis disorders and for nutrition therapy of acute kidney failure. The preparations may be administered both enterally and parenterally, whereby the customary administration forms, e.g. emulsions or oil capsules, are suitable. In addition, they may be used as supplements of the normal diet or in any other coventional preparation form.

Claims

1. Nutriment preparation, comprising:

a glyceride having the general formula;

##STR8## wherein R_1-3 may be the same or different and are selected from the group consisting of hydroxy residues, saturated or unsaturated fatty acid residues having 2 to 24 carbon atoms, and metabolite residues whereby at least two of said residues R_1-3 are metabolite residues, and

wherein said metabolite residues may be the same or different and have the chemical formula;

##STR9## where R is selected from the group consisting of methyl and ethyl residues, m is 0 or 1, and n is 0 or an even number from 2 to 18 provided that when m equals 0 n is greater than or equal to 2 and when n equals 0 m equals 1.

2. Preparation according to claim 1, characterized in that m designates 1 and n designates 0 or an even number from 2 to 6.

3. Preparation according to claim 2, characterized in that n designates 0, 2 or 4.

4. Preparation according to claim 1, wherein all residues R₁, R₂, and R₃ each designate a residue of the Formula:

##STR10##

5. Preparation according to claim 1 wherein all residues R₁, R₂, and R₃ each designate a residue of the Formula ##STR11##

6. Preparation according to claim 1, wherein said glyceride is present in a quantity of 0.2-100% (weight/volume).

7. Preparation according to claim 6, characterized in that it contains the glyceride in a quantity of 0.2-35% (weight/volume).

8. Preparation according to claim 1, comprising a mixture of at least two different glycerides of said glycerides.

9. Preparation according to claim 1, wherein said glycerides are present in a form selected from the group consisting of a combination of animal fats and oils, animal fats, oils, and fractions thereof which are enriched by triglycerides containing branched fatty acids.

10. Preparation according to claim 9, wherein said glycerides are present in the form selected from the group consisting of a combination of fish oil and ruminant fat, fish oil, and ruminant fat.

11. Preparation according to claim 10, characterized in that said glycerides are present in the form of said fractions of said fats and oils enriched by said triglycerides containing branched fatty acids.

12. Preparation according to claim 9, characterized in that said glycerides are present in the form of said fractions of said fats and oils enriched by said triglycerides containing branched fatty acids.

13. Preparation according to claim 1, wherein said glycerides are present in the form of an emulsion of the glyceride in aqueous phase.

14. Preparation according to claim 13, wherein said emulsion contains 2-30% fractionated soy oil, safflower oil, olive oil, fish oil, ruminant fat, cottonseed oil, sunflower oil, triglyceride with an unbranched carbon chain of medium length (MCT) and/or other physiologically acceptable triglycerides of vegetable, animal or synthetic origin.

15. Preparation according to claim 13, wherein said emulsion contains 0.5-10% acetylized mono- or diglycerides of saturated or unsaturated fatty acids with 6 to 24 carbon atoms.

16. Preparation according to claim 14, wherein said emulsion contains 0.5-10% acetylized mono- or diglycerides of saturated or unsaturated fatty acids with 6 to 24 carbon atoms.